Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

ScieGen Pharmaceuticals, a Hauppauge, New York-based generic pharmaceutical company, is voluntarily recalling in the US lots of its irbesartan tablets (USP 75 mg, 150 mg, and 300 mg), an anti-hypertension drug, to the consumer level. The recall is...

Following previously announced plans to restructure its R&D organization, Novo Nordisk has announced that a number of additional restructuring initiatives across functions and geographies have been initiated to support the commercial activities...